Evidence map›Paper›PMID 28717096›Full record

ArticleInternal medicine (Tokyo, Japan)2017

Disseminated Mycobacterium scrofulaceum Infection in an Immunocompetent Host.

Yu Takemoto, Hirokazu Tokuyasu, Tomoyuki Ikeuchi, Hirofumi Nakazaki, Satoru Nakamatsu, Suguru Kakite, Keiichi Yamasaki

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yu TakemotoDepartment of Respiratory Medicine, Matsue Red Cross Hospital, Japan.
Hirokazu TokuyasuDepartment of Respiratory Medicine, Matsue Red Cross Hospital, Japan.
Tomoyuki IkeuchiDepartment of Respiratory Medicine, Matsue Red Cross Hospital, Japan.
Hirofumi NakazakiDepartment of Respiratory Medicine, Matsue Red Cross Hospital, Japan.
Satoru NakamatsuDepartment of Radiology, Matsue Red Cross Hospital, Japan.
Suguru KakiteDepartment of Radiology, Matsue Red Cross Hospital, Japan.
Keiichi YamasakiDepartment of Internal Medicine, Oki Hospital, Japan.
Matsue Red Cross Hospital · JPOki Electric Industry (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 56-year-old woman, without any immunocompromising diseases, was referred to our hospital because of a recurrence of pyogenic spondylitis. Computed tomography revealed multiple osteolytic changes in the whole body. Vertebral magnetic resonance imaging revealed osteomyelitis and spondylitis. Mycobacterium scrofulaceum was detected in sputum cultures, in abscesses from the right knee, and in a subcutaneous forehead abscess. Therefore, the patient was diagnosed with disseminated Mycobacterium scrofulaceum infection. The patient was treated with rifampicin, ethambutol, and clarithromycin, which resulted in symptomatic relief and radiological improvement. We herein report a rare case of disseminated Mycobacterium scrofulaceum infection in an immunocompetent host.

Indexed as

Mycobacterium scrofulaceumAntitubercular AgentsClarithromycinEthambutolFemaleHumansMiddle AgedMycobacterium Infections, NontuberculousOsteomyelitisRifampinAntitubercular AgentsClarithromycinEthambutolRifampinMycobacterium scrofulaceumosteomyelitispyogenic spondylitis

Identifiers

PMID28717096
PMCPMC5548693
OpenAlexW2734852551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.